Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer

NCT05534646 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Castration-resistant Prostate Cancer

Interventions

DRUG: Apalutamide
DRUG: Carotuximab

Sponsor

Edwin Posadas, MD

Collaborators

[object Object]